Ghishan, F. K. & Kiela, P. R. Vitamins and minerals in inflammatory bowel disease. Gastroenterol. Clin. 46, 797–808. https://doi.org/10.1016/j.gtc.2017.08.011 (2017).
Google Scholar
Ulitsky, A. et al. Vitamin D deficiency in patients with inflammatory bowel disease: Association with disease activity and quality of life. JPEN J. Parenter. Enteral Nutr. 35, 308–316. https://doi.org/10.1177/0148607110381267 (2011).
Google Scholar
Torki, M. et al. Vitamin D deficiency associated with disease activity in patients with inflammatory bowel diseases. Dig. Dis. Sci. 60, 3085–3091. https://doi.org/10.1007/s10620-015-3727-4 (2015).
Google Scholar
Lopez-Munoz, P. et al. Influence of vitamin D deficiency on inflammatory markers and clinical disease activity in IBD patients. Nutrients 11, 1059. https://doi.org/10.3390/nu11051059 (2019).
Google Scholar
Jorgensen, S. P. et al. Active Crohn’s disease is associated with low vitamin D levels. J. Crohns Colitis 7, e407-413. https://doi.org/10.1016/j.crohns.2013.01.012 (2013).
Google Scholar
Hausmann, J., Kubesch, A., Amiri, M., Filmann, N. & Blumenstein, I. Vitamin D deficiency is associated with increased disease activity in patients with inflammatory bowel disease. J. Clin. Med. 8, 1319. https://doi.org/10.3390/jcm8091319 (2019).
Google Scholar
Castro, F. D. et al. Lower levels of vitamin D correlate with clinical disease activity and quality of life in inflammatory bowel disease. Arq. Gastroenterol. 52, 260–265. https://doi.org/10.1590/S0004-28032015000400003 (2015).
Google Scholar
Blanck, S. & Aberra, F. Vitamin d deficiency is associated with ulcerative colitis disease activity. Dig. Dis. Sci. 58, 1698–1702. https://doi.org/10.1007/s10620-012-2531-7 (2013).
Google Scholar
Vazquez, M. A. et al. Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: A prospective case-control study. BMC Gastroenterol. 12, 47. https://doi.org/10.1186/1471-230X-12-47 (2012).
Google Scholar
Kuwabara, A. et al. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos. Int. 20, 935–942. https://doi.org/10.1007/s00198-008-0764-2 (2009).
Google Scholar
Siffledeen, J. S., Siminoski, K., Jen, H. & Fedorak, R. N. Vertebral fractures and role of low bone mineral density in Crohn’s disease. Clin. Gastroenterol. Hepatol. 5, 721–728. https://doi.org/10.1016/j.cgh.2007.02.024 (2007).
Google Scholar
Caviezel, D., Maissen, S., Niess, J. H., Kiss, C. & Hruz, P. High prevalence of vitamin D deficiency among patients with inflammatory bowel disease. Inflamm. Intest. Dis. 2, 200–210. https://doi.org/10.1159/000489010 (2018).
Google Scholar
Joseph, A. J., George, B., Pulimood, A. B., Seshadri, M. S. & Chacko, A. 25 (OH) vitamin D level in Crohn’s disease: Association with sun exposure & disease activity. Indian J. Med. Res. 130, 133–137 (2009).
Google Scholar
Suibhne, T. N., Cox, G., Healy, M., O’Morain, C. & O’Sullivan, M. Vitamin D deficiency in Crohn’s disease: Prevalence, risk factors and supplement use in an outpatient setting. J. Crohns Colitis 6, 182–188. https://doi.org/10.1016/j.crohns.2011.08.002 (2012).
Google Scholar
Siffledeen, J. S., Siminoski, K., Steinhart, H., Greenberg, G. & Fedorak, R. N. The frequency of vitamin D deficiency in adults with Crohn’s disease. Can. J. Gastroenterol. 17, 473–478. https://doi.org/10.1155/2003/391308 (2003).
Google Scholar
Abraham, C. & Medzhitov, R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140, 1729–1737. https://doi.org/10.1053/j.gastro.2011.02.012 (2011).
Google Scholar
Ananthakrishnan, A. N. Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 12, 205–217. https://doi.org/10.1038/nrgastro.2015.34 (2015).
Google Scholar
Economou, M. & Pappas, G. New global map of Crohn’s disease: Genetic, environmental, and socioeconomic correlations. Inflamm. Bowel Dis. 14, 709–720. https://doi.org/10.1002/ibd.20352 (2008).
Google Scholar
Moum, B., Aadland, E., Ekbom, A. & Vatn, M. H. Seasonal variations in the onset of ulcerative colitis. Gut 38, 376–378. https://doi.org/10.1136/gut.38.3.376 (1996).
Google Scholar
Yang, C. Y., Leung, P. S., Adamopoulos, I. E. & Gershwin, M. E. The implication of vitamin D and autoimmunity: A comprehensive review. Clin. Rev. Allergy Immunol. 45, 217–226. https://doi.org/10.1007/s12016-013-8361-3 (2013).
Google Scholar
Athanassiou, L., Kostoglou-Athanassiou, I., Koutsilieris, M. & Shoenfeld, Y. Vitamin D and autoimmune rheumatic diseases. Biomolecules 13, 709. https://doi.org/10.3390/biom13040709 (2023).
Google Scholar
Narula, N. & Marshall, J. K. Management of inflammatory bowel disease with vitamin D: Beyond bone health. J. Crohns Colitis 6, 397–404. https://doi.org/10.1016/j.crohns.2011.10.015 (2012).
Google Scholar
Battistini, C., Ballan, R., Herkenhoff, M. E., Saad, S. M. I. & Sun, J. Vitamin D modulates intestinal microbiota in inflammatory bowel diseases. Int. J. Mol. Sci. 22, 362. https://doi.org/10.3390/ijms22010362 (2020).
Google Scholar
Wu, Z., Liu, D. & Deng, F. The role of vitamin D in immune system and inflammatory bowel disease. J. Inflamm. Res. 15, 3167–3185. https://doi.org/10.2147/JIR.S363840 (2022).
Google Scholar
Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911–1930. https://doi.org/10.1210/jc.2011-0385 (2011).
Google Scholar
Cui, A. et al. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. Front. Nutr. 10, 1070808. https://doi.org/10.3389/fnut.2023.1070808 (2023).
Google Scholar
Duranton, F. et al. Vitamin D treatment and mortality in chronic kidney disease: A systematic review and meta-analysis. Am. J. Nephrol. 37, 239–248. https://doi.org/10.1159/000346846 (2013).
Google Scholar
Williams, S., Malatesta, K. & Norris, K. Vitamin D and chronic kidney disease. Ethn. Dis. 19, S5 (2009).
Google Scholar
Brandenburg, V. & Ketteler, M. Vitamin D and secondary hyperparathyroidism in chronic kidney disease: A critical appraisal of the past, present, and the future. Nutrients 14, 3009. https://doi.org/10.3390/nu14153009 (2022).
Google Scholar
Md Isa, Z., Amsah, N. & Ahmad, N. The impact of vitamin D deficiency and insufficiency on the outcome of type 2 diabetes mellitus patients: A systematic review. Nutrients 15, 2310. https://doi.org/10.3390/nu15102310 (2023).
Google Scholar
Norman, P. E. & Powell, J. T. Vitamin D and cardiovascular disease. Circ. Res. 114, 379–393. https://doi.org/10.1161/CIRCRESAHA.113.301241 (2014).
Google Scholar
Pal, E., Ungvari, Z., Benyo, Z. & Varbiro, S. Role of vitamin D deficiency in the pathogenesis of cardiovascular and cerebrovascular diseases. Nutrients 15, 334. https://doi.org/10.3390/nu15020334 (2023).
Google Scholar
Gupta, D., Vashi, P. G., Trukova, K., Lis, C. G. & Lammersfeld, C. A. Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature. Exp. Ther. Med. 2, 181–193. https://doi.org/10.3892/etm.2011.205 (2011).
Google Scholar
Holick, M. F. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 61, 638S-645S. https://doi.org/10.1093/ajcn/61.3.638S (1995).
Google Scholar
Al-Badr, W. & Martin, K. J. Vitamin D and kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1555–1560. https://doi.org/10.2215/CJN.01150308 (2008).
Google Scholar
Dominguez, L. J., Farruggia, M., Veronese, N. & Barbagallo, M. Vitamin D sources, metabolism, and deficiency: Available compounds and guidelines for its treatment. Metabolites 11, 255. https://doi.org/10.3390/metabo11040255 (2021).
Google Scholar
Gubatan, J. et al. Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis. Clin. Gastroenterol. Hepatol. 15, 240–246. https://doi.org/10.1016/j.cgh.2016.05.035 (2017).
Google Scholar
Del Pinto, R., Pietropaoli, D., Chandar, A. K., Ferri, C. & Cominelli, F. Association between inflammatory bowel disease and vitamin D deficiency: A systematic review and meta-analysis. Inflamm. Bowel Dis. 21, 2708–2717. https://doi.org/10.1097/MIB.0000000000000546 (2015).
Google Scholar
Yen, H. H. et al. Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: A nationwide populationbased study. Intest. Res. 17, 54–62. https://doi.org/10.5217/ir.2018.00096 (2019).
Google Scholar
Best, W. R., Becktel, J. M., Singleton, J. W. & Kern, F. Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70, 439–444 (1976).
Google Scholar
Lewis, J. D. et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm. Bowel Dis. 14, 1660–1666. https://doi.org/10.1002/ibd.20520 (2008).
Google Scholar
Lee, M. J. et al. Vitamin D deficiency in northern Taiwan: A community-based cohort study. BMC Public Health 19, 337. https://doi.org/10.1186/s12889-019-6657-9 (2019).
Google Scholar
Guzman-Prado, Y., Samson, O., Segal, J. P., Limdi, J. K. & Hayee, B. Vitamin D therapy in adults with inflammatory bowel disease: A systematic review and meta-analysis. Inflamm. Bowel Dis. 26, 1819–1830. https://doi.org/10.1093/ibd/izaa087 (2020).
Google Scholar
Gubatan, J., Chou, N. D., Nielsen, O. H. & Moss, A. C. Systematic review with meta-analysis: Association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 50, 1146–1158. https://doi.org/10.1111/apt.15506 (2019).
Google Scholar
Shi, S., Feng, J., Zhou, L., Li, Y. & Shi, H. Risk factors for vitamin D deficiency in inflammatory bowel disease: A systematic review and meta-analysis. Turk. J. Gastroenterol. 32, 508–518. https://doi.org/10.5152/tjg.2021.20614 (2021).
Google Scholar
Forbes, A. et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin. Nutr. 36, 321–347. https://doi.org/10.1016/j.clnu.2016.12.027 (2017).
Google Scholar
Park, Y. E. et al. Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behcet’s disease: Folate, vitamin B12, 25-OH-vitamin D, and ferritin. BMC Gastroenterol. 21, 32. https://doi.org/10.1186/s12876-021-01609-8 (2021).
Google Scholar
Ham, N. S. et al. Influence of severe vitamin D deficiency on the clinical course of inflammatory bowel disease. Dig. Dis. Sci. 66, 587–596. https://doi.org/10.1007/s10620-020-06207-4 (2021).
Google Scholar
Nakase, H. et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J. Gastroenterol. 56, 489–526. https://doi.org/10.1007/s00535-021-01784-1 (2021).
Google Scholar
Ran, Z. et al. Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia. J. Gastroenterol. Hepatol. 36, 637–645. https://doi.org/10.1111/jgh.15185 (2021).
Google Scholar
Wei, S. C. et al. Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest. Res. 15, 266–284. https://doi.org/10.5217/ir.2017.15.3.266 (2017).
Google Scholar
Fakhoury, H. M. A. et al. Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation. J. Steroid Biochem. Mol. Biol. 200, 105663. https://doi.org/10.1016/j.jsbmb.2020.105663 (2020).
Google Scholar
Ananthakrishnan, A. N. et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology 142, 482–489. https://doi.org/10.1053/j.gastro.2011.11.040 (2012).
Google Scholar
Xue, L. N. et al. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn’s disease: A meta-analysis. Inflamm. Bowel Dis. 19, 54–60. https://doi.org/10.1002/ibd.22966 (2013).
Google Scholar
Farraye, F. A. et al. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn’s disease. Inflamm. Bowel Dis. 17, 2116–2121. https://doi.org/10.1002/ibd.21595 (2011).
Google Scholar
Han, Y. M. et al. Risk factors for vitamin D, zinc, and selenium deficiencies in Korean patients with inflammatory bowel disease. Gut Liver 11, 363–369. https://doi.org/10.5009/gnl16333 (2017).
Google Scholar
Zullow, S., Jambaulikar, G., Rustgi, A., Quezada, S. & Cross, R. K. Risk factors for vitamin D deficiency and impact of repletion in a tertiary care inflammatory bowel disease population. Dig. Dis. Sci. 62, 2072–2078. https://doi.org/10.1007/s10620-017-4614-y (2017).
Google Scholar
Fletcher, J., Brown, M., Hewison, M., Swift, A. & Cooper, S. C. Prevalence of vitamin D deficiency and modifiable risk factors in patients with Crohn’s disease: A prospective observational study. J. Adv. Nurs. 79, 205–214. https://doi.org/10.1111/jan.15476 (2023).
Google Scholar
Beaugerie, L., Seksik, P., Nion-Larmurier, I., Gendre, J. P. & Cosnes, J. Predictors of Crohn’s disease. Gastroenterology 130, 650–656. https://doi.org/10.1053/j.gastro.2005.12.019 (2006).
Google Scholar
Ha, C. Y., Newberry, R. D., Stone, C. D. & Ciorba, M. A. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin. Gastroenterol. Hepatol. 8, 682–687. https://doi.org/10.1016/j.cgh.2010.03.022 (2010).
Google Scholar
Yen, H. H. et al. Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of Inflammatory Bowel Disease, updated 2023. Intest. Res. (2024) (Accepted).
Sohouli, M. H. et al. Vitamin D therapy in pediatric patients with inflammatory bowel disease: A systematic review and meta-analysis. World J. Pediatr. 19, 48–57. https://doi.org/10.1007/s12519-022-00605-6 (2023).
Google Scholar
Domislovic, V. et al. High prevalence of untreated and undertreated vitamin D deficiency and insufficiency in patients with inflammatory bowel disease. Acta Clin. Croat. 59, 109–118. https://doi.org/10.20471/acc.2020.59.01.13 (2020).
Google Scholar
Tan, B. et al. Treatment of vitamin D deficiency in Chinese inflammatory bowel disease patients: A prospective, randomized, open-label, pilot study. J. Dig. Dis. 19, 215–224. https://doi.org/10.1111/1751-2980.12590 (2018).
Google Scholar
Valvano, M. et al. The usefulness of serum vitamin D levels in the assessment of IBD activity and response to biologics. Nutrients 13, 323. https://doi.org/10.3390/nu13020323 (2021).
Google Scholar
Garg, M., Rosella, O., Lubel, J. S. & Gibson, P. R. Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease. Inflamm. Bowel Dis. 19, 2634–2643. https://doi.org/10.1097/01.MIB.0000436957.77533.b2 (2013).
Google Scholar
Yen, H.-H., Hsu, Y.-C., Kuo, C.-H., Hsu, T.-C. & Chen, Y.-Y. Real-world experience of adalimumab therapy for patients with ulcerative colitis: A single tertiary medical center experience in Central Taiwan. Adv. Dig. Med. 10, 28–33. https://doi.org/10.1002/aid2.13300 (2023).
Google Scholar
Yang, C. T., Yen, H. H., Chen, Y. Y., Su, P. Y. & Huang, S. P. Radiation exposure among patients with inflammatory bowel disease: A single-medical-center retrospective analysis in Taiwan. J. Clin. Med. 11, 5050. https://doi.org/10.3390/jcm11175050 (2022).
Google Scholar
